Schiffl H, Lang S M, Haider M
Medizinische Klinik, Klinikum Innenstadt, University of Munich, Germany.
ASAIO J. 1998 Sep-Oct;44(5):M418-22. doi: 10.1097/00002480-199809000-00019.
The mortality rate of critically ill patients with acute renal failure (ARF) has remained high. The impact of vigorous intermittent hemodialysis (IHD) on the outcome of ARF has not been validated. In this retrospective multicenter analysis, 154 patients with ARF were treated daily (intensive) or on alternate days (conventional) using complement and cell activating cuprophane (bioincompatible) or high-flux polysulfone dialyzer membranes with insignificant effects on circulating complement or cells (biocompatible). At initiation of IHD, all four groups were similar in patient characteristics and ARF factors. The use of synthetic membranes resulted in a reduced mortality rate (18% vs 45%; p < 0.001) and shorter duration of ARF (8 vs 15 sessions; p < 0.001). Daily IHD with cellulose based membranes tended to increase mortality rates compared with conventional cuprophane dialysis (37% vs 53%). Intensive IHD with polysulfone membranes resulted in a further decrease in overall mortality rates (15% vs 22%). This retrospective analysis shows that bioincompatibility of dialyzer membranes may be more important for the outcome of patients with ARF than the dose of dialysis. Its impact on outcome occurs independently of the dose of dialysis delivered.
急性肾衰竭(ARF)重症患者的死亡率一直居高不下。强化间歇性血液透析(IHD)对ARF患者预后的影响尚未得到证实。在这项回顾性多中心分析中,154例ARF患者分别接受每日(强化)或隔日(常规)透析治疗,使用的透析器膜分别为补体和细胞激活型铜仿膜(生物不相容性)或高通量聚砜透析器膜(对循环补体或细胞影响不显著,生物相容性)。在开始IHD时,四组患者的特征和ARF相关因素相似。使用合成膜可降低死亡率(18%对45%;p<0.001),并缩短ARF持续时间(8次对15次;p<0.001)。与传统铜仿膜透析相比,基于纤维素膜的每日IHD有增加死亡率的趋势(37%对53%)。使用聚砜膜进行强化IHD可进一步降低总体死亡率(15%对22%)。这项回顾性分析表明,透析器膜的生物不相容性对ARF患者的预后可能比透析剂量更为重要。其对预后的影响独立于所给予的透析剂量。